Methylphenidat-Hcl Medice (Methylphenidate Hydrochloride)

Methylphenidate hydrochloride works by inhibiting the reuptake of the neurotransmitters dopamine and norepinephrine at neuronal synapses. This inhibition raises the levels of these catecholamines in the brain, enhancing signaling in pathways that control attention, impulse control, and wakefulness, which underlies its therapeutic effects in ADHD and narcolepsy.

The appropriate dose of Methylphenidat-Hcl Medice is determined individually by a qualified prescriber based on the patient’s age, clinical response, and tolerability. Healthcare professionals consider factors such as severity of symptoms, prior treatment history, and any co‑existing medical conditions when establishing the dosing regimen.

Safety data for methylphenidate use in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should discuss risks with their healthcare provider, as the drug can be excreted in breast milk and may affect the infant.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Methylphenidate is a psychostimulant that directly increases dopamine and norepinephrine levels, similar to other stimulants like amphetamine derivatives. Compared with non‑stimulant options such as atomoxetine, methylphenidate generally has a faster onset of action and may be more effective for certain patients, but individual response and side‑effect profiles vary.

Methylphenidat-Hcl Medice should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and potency throughout its shelf life.

The medication is taken orally, usually in tablet form, as directed by a healthcare professional. It is commonly taken once or multiple times per day, with or without food, depending on the prescribed dosing schedule. Patients should follow the prescriber’s instructions and not alter the dosing regimen without medical advice.

Serious risks include cardiovascular events such as hypertension, arrhythmias, or myocardial infarction, as well as psychiatric effects like psychosis, severe agitation, or emergence of suicidal thoughts. Rare but severe allergic reactions, including anaphylaxis, may also occur. Patients should be monitored closely for any concerning symptoms.

Methylphenidat-Hcl Medice is contraindicated in individuals with known hypersensitivity to methylphenidate or any of its excipients, those who have taken monoamine oxidase inhibitors within the past 14 days, and patients with certain cardiovascular conditions where stimulant use is unsafe. A prescriber should evaluate each patient’s medical history before initiating therapy.